Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
184A1 |
Human immortalized mammary epithelial cells | ATCC CRL-8798 | Human | breast | cell line | adherent | plasmid | Metafectene | publication | K. Konopka et al., Cell Mol Biol Lett, Jan 2009; 14(1): 70-89 | |||
4T1 |
Mouse mammary gland cell line | ATCC CRL-2539 | Mouse | breast | cell line | adherent | plasmid | Metafectene PRO | publication | V. P. Baklaushev et al., Cell Technologies in Biol. and Med., 2015, 4: 581-588; DOI 10.1007/s10517-015-2810-3 | |||
BT-474 |
ATCC HTB-20 | breast | cell line | adherent | plasmid | Metafectene PRO | publication | V. Vella et al., Oncotarget, 2017, 8 (26): 43248-43270 | Link | ||||
HBL 100 |
Human transformed breast cells | Human | breast | cell line | adherent | plasmid | Metafectene | application note | ![]() |
||||
HBL 100 |
Human transformed epithelial cell line | Human | breast | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | A. M. Scherbakov et al., Exp. Cell Res., 2013, 319: 3150 – 3159, doi.org/10.1016/j.yexcr.2013.08.019 | |||
HBL 100 |
Human transformed epithelial cell line | Human | breast | cell line | adherent | plasmid | Metafectene | publication | A. M. Scherbakov et al., J. of Cellular Biochem., 2012, 113: 2147–2155 | ||||
HBL 100 |
Human transformed epithelial cell line | Human | breast | cell line | adherent | plasmid | cotransfection (plasmid/siRNA) | Metafectene PRO | publication | A. M. Scherbakov et al., Exp. Cell Res., 2013, 319: 3150 – 3159, doi.org/10.1016/j.yexcr.2013.08.019 | |||
HC11 |
Mouse immortalized prolactin-responsive mammary epithelial cells | ATCC CRL-3062 | Mouse | breast | cell line | adherent | plasmid | Metafectene | publication | J. Seong., PhD Thesis, Seoul National University | Link | ||
HC11 |
Mouse immortalized prolactin-responsive mammary epithelial cells | ATCC CRL-3062 | Mouse | breast | cell line | adherent | plasmid | Metafectene | publication | J. Seong et al., Development, 2018, 145: dev165258, doi:10.1242/dev.165258 | Link | ||
hMEC |
Human normal mammary epithelial cells | ATCC PCS-600-010 | Human | breast | unknown | adherent | plasmid | Metafectene PRO | publication | A. Ray et al., Mol. Cancer Res., Aug 2011; 9: 1030 - 1041 | Link | ||
hMEC |
Human normal mammary epithelial cells | ATCC PCS-600-010 | Human | breast | unknown | adherent | plasmid | Metafectene PRO | application note | ![]() |
|||
hMEC |
Human normal mammary epithelial cells | ATCC PCS-600-010 | Human | breast | unknown | adherent | plasmid | Metafectene PRO | application note | ![]() |
|||
HT-1080 |
Human breast fibrocarcinoma cell line | ATCC CCL-121 | Human | breast | cell line | adherent | plasmid | Metafectene PRO | application note | ![]() |
|||
HT-1080 |
Human breast fibrocarcinoma cell line | ATCC CCL-121 | Human | breast | cell line | adherent | plasmid | Metafectene PRO | application note | ![]() |
|||
M3K |
Drug-resistant breast cancer cell line (derivative of MCF7) | Human | breast | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | L. J. Barlow, Dissertation, 2020, University Graduate School | Link | ||
MC4-L2 |
Mouse mammary carcinoma cell line | Mouse | breast | cell line | adherent | plasmid | K2 Transfection System | publication | W. Wang et al., Mol. and Cellular Endocrinology, 2018, 477: 57–69, doi.org/10.1016/j.mce.2018.06.001 | Link | |||
MC4-L3 |
Mouse mammary carcinoma cell line | Mouse | breast | cell line | adherent | plasmid | K2 Transfection System | publication | W. Wang et al., Mol. and Cellular Endocrinology, 2018, 477: 57–69, doi.org/10.1016/j.mce.2018.06.001 | Link | |||
MC7-L1 |
Mouse mammary carcinoma cell line | Mouse | breast | cell line | adherent | plasmid | K2 Transfection System | application note | ![]() |
||||
MC7-L1 |
Mouse mammary carcinoma cell line | Mouse | breast | cell line | adherent | plasmid | K2 Transfection System | publication | W. Wang et al., Mol. and Cellular Endocrinology, 2018, 477: 57–69, doi.org/10.1016/j.mce.2018.06.001 | Link | |||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | Metafectene PRO | publication | D. Sorokin et al., Pharmaceuticals, 2020, 13(9): 206, doi.org/10.3390/ph13090206 | Link | ||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | K2 Transfection System | publication | V. Morales-Garcia et al., FEBS Open Bio 10, 2020, 2541–2552, doi:10.1002/2211-5463.12987 | |||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | Metafectene PRO | publication | V. Vella et al., Endocrine-Related Cancer, 2019, 26: 197–214, doi.org/10.1530/ERC-18-0310 | |||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | Metafectene | publication | Y. V. Kuznetsov et al., Eur. J. of Medicinal Chemistry, 2018, 143: 670e682, doi.org/10.1016/j.ejmech.2017.11.042 | Link | ||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | Metafectene | publication | Y. V. Kuznetsov et al., Steroids, 2018, doi.org/10.1016/j.steroids.2018.07.007 | |||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | Metafectene | publication | A. M. Scherbakov et al., IUBMB, 2016, 68 (4): 281-292; DOI 10.1002/iub.1481 | Link |